Moderna target nearly halved by Morgan Stanley on weak guidance

Moderna Target Nearly Halved By Morgan Stanley On Weak Guidance

2 weeks from now

15 hours ago  · Investing.com -- Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and …

yahoo.com

Moderna Price Target Lowered To $38 From $70 At Morgan Stanley

2 weeks from now

1 day ago  · Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna to $38 from $70 and keeps an Equal Weight rating on the shares after the company announced …

businessinsider.com

Morgan Stanley Cuts Price Target On Moderna To $38 From $70, …

2 weeks from now

19 hours ago  · Morgan Stanley Cuts Price Target on Moderna to $38 From $70, Keeps Equalweight Rating January 15, 2025 at 06:22 am EST Share ... Moderna Shares Fall After …

marketscreener.com

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, …

msn.com

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024  · The J.P. Morgan analysts downgraded Moderna's stock to underweight from neutral, and cut their price target to $70, from $88. Moderna's stock is down 33% in the year to …

morningstar.com

Moderna Price Target Lowered To $70 From $94 At Morgan Stanley

2 weeks from now

Morgan Stanley lowered the firm’s price target on Moderna to $70 from $94 and keeps an Equal Weight rating on the shares. The firm is updating its model to reflect the company’s pipeline …

tipranks.com

Unveiling 18 Analyst Insights On Moderna - Nasdaq

2 weeks from now

Oct 15, 2024  · 18 analysts have expressed a variety of opinions on Moderna ... featuring an average target of $102.44, a high estimate of $178.00, and a low estimate of $55.00. ...

nasdaq.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

Moderna Price Target Lowered By $23 At Morgan Stanley, Here’s Why

2 weeks from now

Dec 12, 2023  · Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna to $92 from $115 and keeps an Equal Weight rating on the shares. In offering a 2024 outlook …

tipranks.com

Breaking Down Moderna: 7 Analysts Share Their Views

2 weeks from now

Jun 3, 2024  · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $132.14, with a high estimate of $163.00 and a low estimate of $106.00.

nasdaq.com

Morgan Stanley Maintains Equal-Weight On Moderna, Lowers …

2 weeks from now

Oct 18, 2022  · Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $197 to $175.

benzinga.com

Moderna Price Target Lowered To $59 From $70 At JPMorgan

2 weeks from now

Nov 4, 2024  · JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $59 from $70 and keeps an Underweight rating on the shares. The firm updated estimates …

nasdaq.com

Morgan Stanley: Moderna Has Significant Competitive Advantage

2 weeks from now

Jan 2, 2019  · Morgan Stanley analyst Matthew Harrison initiated coverage of Moderna with an Overweight rating and $29 price target. The Thesis. Moderna has significant competitive …

benzinga.com

Moderna Price Target Lowered To $45 From $59 At JPMorgan

2 weeks from now

Nov 26, 2024  · JPMorgan lowered the firm’s price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated estimates for the company …

nasdaq.com

MORGAN STANLEY: Moderna Could Double After The Biotech's …

2 weeks from now

Jan 6, 2019  · Morgan Stanley had the highest price target among analyst notes reviewed by Business Insider, at $29. ... Key Moderna price targets include: Morgan Stanley: $29; ... That's …

businessinsider.com

Moderna: Pipeline Development Is The Key In 2022, Says Morgan …

2 weeks from now

Feb 28, 2022  · The company also announced a $3 billion share buyback program.Morgan Stanley’s Matthew Harrison counts this development along with the strong guidance as the …

nasdaq.com